Hologic presents its MammoSite ML for Radiation Therapy

Hologic featured its next-generation MammoSite ML (multi-lumen) radiation therapy system at the American Society of Radiation Oncology (ASTRO) meeting. By employing the MammoSite system, the radiation oncologist can deliver targeted radiation therapy directly to the area where cancer is most likely to recur, allowing a full course of radiation to be delivered in just five days. Additionally, targeted therapy of the breast limits radiation exposure to normal, healthy tissue. This targeting helps minimize side effects such as skin discoloration and scarring, burning, fatigue, and damage to surrounding organs .This new version of the system gives radiation oncologists the ability to shape the radiation dose for typical cases and treat patients who are otherwise not appropriate candidates for traditional brachytherapy.